Espharm, s.r.o.Active
People and shareholders
Executive director (konateľ) · 2024
Executive director (konateľ) · 2024
Executive director (konateľ) · 2024
Executive director (konateľ) · 2013
Shareholder · 5 000 € · 2022
Authorised officer (prokurista) · 2025
Former persons (3)
Shareholder · 2013–2022
Executive director (konateľ) · 2011–2013
Shareholder · 2011–2013
Source: Register of Legal Entities (Statistical Office SR). Only name and position are shown — no address or date of birth.
Key figures
Key figures
2025Balance sheet structure
Summary of annual reports2020–2025
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|
| Balance sheet — assets | ||||||
| Total current assets | 1 168 561 | 1 204 372 | 1 266 990 | 1 231 821 | 1 177 793 | 1 327 939 |
| Total non-current assets | 39 226 | 29 769 | 421 798 | 539 364 | 589 660 | 586 100 |
| Total assets | 1 208 765 | 1 235 128 | 1 691 194 | 1 773 364 | 1 768 006 | 1 914 380 |
| Balance sheet — liabilities and equity | ||||||
| Total liabilities | 281 720 | 69 595 | 359 559 | 381 428 | 282 004 | 354 394 |
| Share capital | 5 000 | 5 000 | 5 000 | 5 000 | 5 000 | 5 000 |
| Profit for the year (equity) | 244 639 | 238 488 | 164 917 | 61 486 | 93 636 | 72 568 |
| Total equity | 927 045 | 1 165 533 | 1 330 450 | 1 391 936 | 1 485 572 | 1 558 140 |
| Income statement | ||||||
| Revenue (net turnover) | 3 016 730 | 2 934 853 | 2 881 784 | 3 029 681 | 3 097 058 | 3 202 129 |
| Operating profit | 319 298 | 314 070 | 233 345 | 99 119 | 144 216 | 110 172 |
| EBITDA | 328 208 | 323 527 | 261 802 | 99 119 | 183 197 | 113 732 |
| Profit before income tax | 310 416 | 305 014 | 216 065 | 83 219 | 125 884 | 95 928 |
| Profit for the reporting year | 244 639 | 238 488 | 164 917 | 61 486 | 93 636 | 72 568 |
| Labour costs | 102 510 | 114 703 | 124 540 | 156 224 | 187 805 | 190 580 |
| Depreciation of non-current assets | 8 910 | 9 457 | 28 457 | 0 | 38 981 | 3 560 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Summary: Espharm, s.r.o.
Overview
Espharm, s.r.o. (IČO 46356436) is a limited liability company (s.r.o.). The company was incorporated in 2011 and has existed for 15 years. Registered office according to the register: Senec. Main activity according to the Statistical Office: poradenské služby v oblasti podnikania a riadenia (SK NACE 7020). Size category by number of employees: 10–19 employees.
People
The statutory body has 4 members. According to the register, the company has one shareholder. The registered capital is 5 000 €.
Financial results
Revenue for 2025 was 3 202 129 €, up 3,4 % on the previous year (3 097 058 €). From 2020 to 2025, revenue grew by an average of 1,2 % per year. This is the highest revenue in the reported years (2020–2025). Net profit for 2025 was 72 568 € (2,3 % of revenue). The company was profitable in all 6 reported years. Personnel costs for 2025 were 190 580 €. At the end of 2025 the company had total assets of 1 914 380 € and equity of 1 558 140 € (equity ratio 81,4 %).
Sources and freshness
Company and people data come from the Register of Legal Entities (Statistical Office SR, CC BY 4.0) and financial statements from the Register of Financial Statements (Ministry of Finance SR); icoprofil.sk updates them daily. Data as of 19. 10. 2026. Changes, averages and ratios are calculated by icoprofil.sk from open data and are not an official assessment.